Literature DB >> 31154603

Identification of novel rhesus macaque microRNAs from naïve whole blood.

Mary S Lopez1,2,3, Jeanette M Metzger1,4, Marina E Emborg5,6,7.   

Abstract

MicroRNAs (miRNAs) are emerging as novel molecular tools for diagnosing and treating diseases. Rhesus monkeys (Macaca mulatta) are the most widely used nonhuman primate species for biomedical studies, yet only 912 mature miRNAs have been identified in this species compared to 2654 in humans and 1978 in mice. The aim of this project was to help bridge that gap in knowledge by evaluating circulating miRNA in naïve rhesus monkeys and comparing results with currently available databases in different species in order to identify novel, mature miRNAs. Total RNA was isolated from whole blood of ten healthy, adult rhesus macaques. After performing next generation sequencing (NGS), 475 novel, mature miRNAs were identified in rhesus macaques for the first time; of those, 423 were identified for the first time in any species. The most abundantly expressed novel rhesus macaque miRNA, hsa-miR-744-5p, has previously been described in humans. Database assessment of hsa-miR-744-5p potential gene targets showed that while the gene targets showed > 90% sequence similarity between rhesus and humans, many did not share the same consensus sequences. The identification of 475 novel miRNAs in the blood of rhesus macaque reflects the complexity and variety of miRNAs across species. Further NGS studies are needed to reveal novel miRNA that will inform on species-, tissue-, and condition-specific miRNAs.

Entities:  

Keywords:  MicroRNA; Monkeys; Next generation sequencing; Non-coding RNA; Rhesus

Mesh:

Substances:

Year:  2019        PMID: 31154603      PMCID: PMC6778012          DOI: 10.1007/s11033-019-04891-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  24 in total

Review 1.  MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment.

Authors:  Daniel Quiat; Eric N Olson
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

Review 2.  Impact of microRNAs on ischemic stroke: From pre- to post-disease.

Authors:  Guangwen Li; Kahlilia C Morris-Blanco; Mary S Lopez; Tuo Yang; Haiping Zhao; Raghu Vemuganti; Yumin Luo
Journal:  Prog Neurobiol       Date:  2017-08-24       Impact factor: 11.685

3.  Hepatitis C virus RNA functionally sequesters miR-122.

Authors:  Joseph M Luna; Troels K H Scheel; Tal Danino; Katharina S Shaw; Aldo Mele; John J Fak; Eiko Nishiuchi; Constantin N Takacs; Maria Teresa Catanese; Ype P de Jong; Ira M Jacobson; Charles M Rice; Robert B Darnell
Journal:  Cell       Date:  2015-03-12       Impact factor: 41.582

Review 4.  Why primate models matter.

Authors:  Kimberley A Phillips; Karen L Bales; John P Capitanio; Alan Conley; Paul W Czoty; Bert A 't Hart; William D Hopkins; Shiu-Lok Hu; Lisa A Miller; Michael A Nader; Peter W Nathanielsz; Jeffrey Rogers; Carol A Shively; Mary Lou Voytko
Journal:  Am J Primatol       Date:  2014-04-10       Impact factor: 2.371

Review 5.  Many roads to maturity: microRNA biogenesis pathways and their regulation.

Authors:  Julia Winter; Stephanie Jung; Sarina Keller; Richard I Gregory; Sven Diederichs
Journal:  Nat Cell Biol       Date:  2009-03       Impact factor: 28.824

6.  MicroRNA: Biogenesis, Function and Role in Cancer.

Authors:  Leigh-Ann Macfarlane; Paul R Murphy
Journal:  Curr Genomics       Date:  2010-11       Impact factor: 2.236

7.  Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis.

Authors:  Xin Guo; Xiaohui Lv; Xing Lv; Yueyun Ma; Lin Chen; Yong Chen
Journal:  Oncotarget       Date:  2017-07-04

Review 8.  The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis.

Authors:  Qiliang Peng; Xueli Zhang; Ming Min; Li Zou; Peipei Shen; Yaqun Zhu
Journal:  Oncotarget       Date:  2017-07-04

9.  Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.

Authors:  Kai Qu; Xing Zhang; Ting Lin; Tian Liu; Zhixin Wang; Sushun Liu; Lei Zhou; Jichao Wei; Hulin Chang; Ke Li; Zheng Wang; Chang Liu; Zheng Wu
Journal:  Sci Rep       Date:  2017-05-10       Impact factor: 4.379

Review 10.  Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine.

Authors:  Chiranjib Chakraborty; Ashish Ranjan Sharma; Garima Sharma; C George Priya Doss; Sang-Soo Lee
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-12       Impact factor: 8.886

View more
  1 in total

1.  Effects of Cardiac Sympathetic Neurodegeneration and PPARγ Activation on Rhesus Macaque Whole Blood miRNA and mRNA Expression Profiles.

Authors:  Jeanette M Metzger; Mary S Lopez; Jenna K Schmidt; Megan E Murphy; Raghu Vemuganti; Marina E Emborg
Journal:  Biomed Res Int       Date:  2020-05-02       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.